You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 9,233,097


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,233,097 protect, and when does it expire?

Patent 9,233,097 protects TPOXX and is included in one NDA.

This patent has twenty-two patent family members in fourteen countries.

Summary for Patent: 9,233,097
Title:ST-246 liquid formulations
Abstract: The present invention provides for a novel liquid formulation for solubilizing poorly soluble ST-246 in cyclodextrins and a novel process of making the formulation.
Inventor(s): Tyavanagimatt; Shanthakumar R. (Corvallis, OR), Stone; Melialani A. C. L. (Corvallis, OR), Weimers; William C. (Corvallis, OR), Kasi; Gopi Krishna (Corvallis, OR), Samuel; Peter N. K. (Corvallis, OR), Bolken; Tove (Keizer, OR), Hruby; Dennis E. (Albany, OR)
Assignee: SIGA TECHNOLOGIES, INC. (Corvallis, OR)
Application Number:13/814,102
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,233,097

Introduction

United States Patent 9,233,097, titled "ST-246 liquid formulations," is a patent that introduces a novel liquid formulation for solubilizing poorly soluble ST-246, a compound often used in medical treatments. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication Number and Status

  • The patent number is US9233097B2, and it is currently active[3].

Claims Analysis

Independent and Dependent Claims

The patent includes several claims, both independent and dependent, which define the scope of the invention.

  • Independent Claims: These claims stand alone and define the core aspects of the invention. For example, Claim 1 might describe the novel liquid formulation comprising ST-246 and cyclodextrins, while Claim 2 could describe a method of making this formulation[3].

  • Dependent Claims: These claims build upon the independent claims and provide additional details or variations. For instance, a dependent claim might specify the concentration of ST-246 in the formulation or the type of cyclodextrin used[3].

Claim Scope and Concepts

To understand the full scope of the patent, it is crucial to analyze the claims in the context of scope concepts. This involves categorizing the claims by their overarching concepts, such as the use of cyclodextrins, the solubilization method, and the application of the formulation (e.g., oral or infusion)[4].

Scope of the Invention

Technical Details

  • ST-246 Solubilization: The patent focuses on improving the solubility of ST-246, a compound that is otherwise poorly soluble. The use of cyclodextrins is a key innovation, as these molecules can form inclusion complexes that enhance the solubility of ST-246[3].

  • Formulation Types: The patent describes various formulations, including oral and infusion forms, each with specific compositions and methods of preparation. This diversity in formulation types expands the potential applications of the invention[3].

Classification and Categories

The patent is classified under several categories, including:

  • A61K31/403: Heterocyclic compounds having nitrogen as a ring hetero atom.
  • A61K47/6949: Medicinal preparations characterized by non-active ingredients, such as carriers or inert additives.
  • A61P17/00: Drugs for dermatological disorders[3].

These classifications help in understanding the broader technological and medical contexts in which the patent operates.

Patent Landscape

Global Dossier and International Search

To assess the global patent landscape, tools like the Global Dossier and international patent databases are essential. These resources allow users to see the patent family for a specific application, including related applications filed at participating IP Offices, and access dossier, classification, and citation data[1].

Prior Art and Citation Data

The Common Citation Document (CCD) application is useful for consolidating prior art cited by all participating offices for the family members of a patent application. This helps in identifying any overlapping or similar inventions that have been patented elsewhere[1].

Competitor Analysis

Analyzing the patent landscape involves identifying competitors who may hold similar or related patents. Tools like Patent Analytics can help in tracking patents by claims and scope concepts, making it easier to determine gaps or opportunities in the market[4].

Economic and Legal Implications

Patent Litigation

The patent's validity and enforceability can be affected by factors such as patent litigation trends. Studies by the GAO have highlighted the importance of linking patent litigation data with internal patent examination processes to improve patent quality and reduce litigation risks[5].

Market Value

The value of the patent claims can be assessed using tools like ClaimScape®, which categorizes claims by their scope concepts and helps in determining their current and future value to the company. This can guide strategic decisions on maintaining or expanding the patent portfolio[4].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for defining the scope of the invention.
  • Scope Concepts: Categorizing claims by overarching scope concepts helps in analyzing the patent landscape efficiently.
  • Global Context: Using tools like Global Dossier and CCD to assess the international patent landscape is essential.
  • Economic and Legal Implications: Analyzing patent litigation trends and the market value of claims can inform strategic decisions.

FAQs

Q: What is the main innovation of United States Patent 9,233,097? A: The main innovation is the use of cyclodextrins to improve the solubility of ST-246.

Q: How can the scope of the patent be analyzed? A: The scope can be analyzed by categorizing the claims by their overarching scope concepts and understanding the technical details of the formulation.

Q: What tools are available for assessing the global patent landscape? A: Tools like the Global Dossier, CCD, and international patent databases are available.

Q: How can the economic value of the patent claims be determined? A: Tools like ClaimScape® can help in categorizing claims by their scope concepts and determining their current and future value.

Q: What is the significance of linking patent litigation data with internal patent examination processes? A: This linkage can help in improving patent quality and reducing litigation risks.

Sources

  1. USPTO - Search for patents.
  2. USPTO - Patent Claims Research Dataset.
  3. Google Patents - US9233097B2.
  4. SLWIP - Patent Analytics.
  5. GAO - Assessing Factors That Affect Patent Infringement Litigation.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,233,097

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Siga Technologies TPOXX tecovirimat SOLUTION;INTRAVENOUS 214518-001 May 18, 2022 RX Yes Yes 9,233,097 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,233,097

PCT Information
PCT FiledAugust 02, 2011PCT Application Number:PCT/US2011/046260
PCT Publication Date:February 09, 2012PCT Publication Number: WO2012/018810

International Family Members for US Patent 9,233,097

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 082566 ⤷  Subscribe
Argentina 122178 ⤷  Subscribe
Australia 2011285871 ⤷  Subscribe
Brazil 112013002646 ⤷  Subscribe
Canada 2807528 ⤷  Subscribe
China 103281898 ⤷  Subscribe
China 106074370 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.